LifeVantage reports fiscal 2026 financial results highlighting revenue declines
Annual revenue fell to $182.6 million while net income dropped to $5.1 million as active accounts decreased and macroeconomic headwinds weighed on sales performance.
See the latest news and media coverage for LifeVantage. We track all announcements, press releases, and industry mentions in real time, all in one place.
Nutrigenomics and wellness products company
lifevantage.comLast updated
In short: LifeVantage appointed Terrence Moorehead as CEO and reported fiscal 2026 revenue declines, with annual revenue of $182.6 million.
Annual revenue fell to $182.6 million while net income dropped to $5.1 million as active accounts decreased and macroeconomic headwinds weighed on sales performance.
Results release is scheduled after market close on August 27, 2026, with an investor conference call at 2:30 p.m. Mountain Time and a simultaneous live webcast.
He brings over 25 years of global leadership in consumer wellness and previously led Nature's Sunshine Products as President and CEO.
Revenue decreased 25% to $43.7 million, net income per share $0.11, and adjusted EBITDA $3.2 million.
Lifevantage (NASDAQ:LFVN) executives outlined a turnaround plan centered on strengthening the compan...
LifeVantage stock traded at USD 6.35 on Nasdaq on September 18, 2026, with after-hours trading at USD 6.36 and volume of ...
The LifeVantage stock reflects a stable development after the latest quarterly figures, while the company is relying on its distribution networks and products.
LifeVantage entered fiscal 2027 with a debt-free balance sheet, a gross margin near 80% and substantial remaining share-repurchase capacity as newly appointed Chief Executive Officer...
Track LifeVantage and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to LifeVantage and other trending companies.